Cross-sectional evaluation of people with type 1 diabetes participating in the GoPump Structured Diabetes Education Program during "Insulin Pump Weeks".

Q3 Medicine
Marta Najmanowicz, Weronika Gajda, Aleksandra Nowatkowska, Mikołaj Kamiński, Aleksandra Cieluch, Alicja Sroczyńska, Anna Kreczmer, Magdalena Michalak, Anna Adamska, Urszula Frąckowiak, Mateusz Michalski, Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Andrzej Gawrecki
{"title":"Cross-sectional evaluation of people with type 1 diabetes participating in the GoPump Structured Diabetes Education Program during \"Insulin Pump Weeks\".","authors":"Marta Najmanowicz, Weronika Gajda, Aleksandra Nowatkowska, Mikołaj Kamiński, Aleksandra Cieluch, Alicja Sroczyńska, Anna Kreczmer, Magdalena Michalak, Anna Adamska, Urszula Frąckowiak, Mateusz Michalski, Aleksandra Araszkiewicz, Dorota Zozulińska-Ziółkiewicz, Andrzej Gawrecki","doi":"10.5114/pedm.2025.148400","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Despite advances in therapy, most persons with type 1 diabetes (PwT1Ds) do not achieve treatment goals. Education is fundamental to the care of PwT1Ds treated with continuous subcutaneous insulin infusion (CSII).</p><p><strong>Aim of the study: </strong>To evaluate PwT1Ds treated with CSII and receiving in-hospital education and to identify factors associated with treatment effectiveness.</p><p><strong>Material and methods: </strong>This cross-sectional study included adults with type 1 diabetes (T1D), who received diabetes education using the proprietary Structured Diabetes Education Program, GoPump, during \"Insulin Pump Weeks\" in 2022-2023. Metabolic control of diabetes was evaluated. Reports from personal insulin pumps, blood glucose meters, and continuous glucose monitoring (CGM) systems were assessed.</p><p><strong>Results: </strong>Data from 107 individuals with a median age of 26.7 years (Q1-Q3: 19.0-30.8) were analysed, including 65 women (60.7%). The median duration of T1D was 13 years (Q1-Q3: 10.0-18.0), and the median duration of personal insulin pump use was 8 years (Q1-Q3: 5.0-12.0). The median body mass index was 23.9 kg/m². CGM was used by 52.3% of individuals. The median time in range (TIR) was 57.0% (Q1-Q3: 45.0-69.5%), and the median glycated haemoglobin (HbA1c) level was 7.9% (Q1-Q3: 6.8-8.5%). A positive correlation was found between age and TIR (rs = 0.42, p = 0.001). The use of temporary basal rate and dual-wave and square bolus features was positively correlated with TIR (rs = 0.34, p = 0.012 and rs = 0.31, p = 0.021, respectively) and inversely with time above range > 250 mg/dl (rs = -0.37, p = 0.007 and rs = -0.27, p = 0.045, respectively). Lower HbA1c levels were observed in individuals with a higher number of daily boluses (rs = -0.33, p = 0.001).</p><p><strong>Conclusions: </strong>In the study cohort, older age, more frequent use of advanced insulin pump features, and a higher number of daily boluses were associated with better glycaemic control in adults with T1D.</p>","PeriodicalId":39165,"journal":{"name":"Pediatric Endocrinology, Diabetes and Metabolism","volume":"31 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12051104/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Endocrinology, Diabetes and Metabolism","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5114/pedm.2025.148400","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Despite advances in therapy, most persons with type 1 diabetes (PwT1Ds) do not achieve treatment goals. Education is fundamental to the care of PwT1Ds treated with continuous subcutaneous insulin infusion (CSII).

Aim of the study: To evaluate PwT1Ds treated with CSII and receiving in-hospital education and to identify factors associated with treatment effectiveness.

Material and methods: This cross-sectional study included adults with type 1 diabetes (T1D), who received diabetes education using the proprietary Structured Diabetes Education Program, GoPump, during "Insulin Pump Weeks" in 2022-2023. Metabolic control of diabetes was evaluated. Reports from personal insulin pumps, blood glucose meters, and continuous glucose monitoring (CGM) systems were assessed.

Results: Data from 107 individuals with a median age of 26.7 years (Q1-Q3: 19.0-30.8) were analysed, including 65 women (60.7%). The median duration of T1D was 13 years (Q1-Q3: 10.0-18.0), and the median duration of personal insulin pump use was 8 years (Q1-Q3: 5.0-12.0). The median body mass index was 23.9 kg/m². CGM was used by 52.3% of individuals. The median time in range (TIR) was 57.0% (Q1-Q3: 45.0-69.5%), and the median glycated haemoglobin (HbA1c) level was 7.9% (Q1-Q3: 6.8-8.5%). A positive correlation was found between age and TIR (rs = 0.42, p = 0.001). The use of temporary basal rate and dual-wave and square bolus features was positively correlated with TIR (rs = 0.34, p = 0.012 and rs = 0.31, p = 0.021, respectively) and inversely with time above range > 250 mg/dl (rs = -0.37, p = 0.007 and rs = -0.27, p = 0.045, respectively). Lower HbA1c levels were observed in individuals with a higher number of daily boluses (rs = -0.33, p = 0.001).

Conclusions: In the study cohort, older age, more frequent use of advanced insulin pump features, and a higher number of daily boluses were associated with better glycaemic control in adults with T1D.

在“胰岛素泵周”期间参加GoPump结构化糖尿病教育计划的1型糖尿病患者的横断面评估
导读:尽管治疗取得了进展,但大多数1型糖尿病患者(PwT1Ds)并没有达到治疗目标。教育是持续皮下胰岛素输注(CSII)治疗的PwT1Ds护理的基础。本研究的目的:评估接受CSII治疗的PwT1Ds和接受住院教育的情况,并确定与治疗效果相关的因素。材料和方法:本横断面研究纳入了2022-2023年“胰岛素泵周”期间使用专有的结构化糖尿病教育计划GoPump接受糖尿病教育的1型糖尿病(T1D)成人。评估糖尿病的代谢控制。评估个人胰岛素泵、血糖仪和连续血糖监测(CGM)系统的报告。结果:分析了107例患者的数据,中位年龄为26.7岁(Q1-Q3: 19.0-30.8岁),其中65例为女性(60.7%)。T1D的中位病程为13年(Q1-Q3: 10.0-18.0),个人胰岛素泵使用的中位病程为8年(Q1-Q3: 5.0-12.0)。身体质量指数中位数为23.9 kg/m²。52.3%的人使用CGM。中位范围时间(TIR)为57.0% (Q1-Q3: 45.0-69.5%),中位糖化血红蛋白(HbA1c)水平为7.9% (Q1-Q3: 6.8-8.5%)。年龄与TIR呈正相关(rs = 0.42, p = 0.001)。临时基础率、双波和方块特征的使用与TIR呈正相关(rs = 0.34, p = 0.012和rs = 0.31, p = 0.021),与时间高于> 250 mg/dl呈负相关(rs = -0.37, p = 0.007和rs = -0.27, p = 0.045)。在每日服用剂量较高的个体中,HbA1c水平较低(rs = -0.33, p = 0.001)。结论:在研究队列中,年龄越大,更频繁地使用先进的胰岛素泵功能,以及更多的每日剂量与T1D成人患者更好的血糖控制相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pediatric Endocrinology, Diabetes and Metabolism
Pediatric Endocrinology, Diabetes and Metabolism Medicine-Pediatrics, Perinatology and Child Health
CiteScore
2.00
自引率
0.00%
发文量
36
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信